J&J CEO sends a clear message on the obesity drug boom
Johnson & Johnson (JNJ) just told Wall Street it will sit out the most lucrative drug race of the decade. The decision came straight from the top, at a public event in Washington, on June 16, and it surprised investors who assumed a large drugmaker like J&J would want a piece of the ...
The Source
THE STREET
Business
Final stage of the bull market? What to do with your money now
THE STREET·49m ago·3 min read
Business
OpenAI, Cerebras deal was supposed to be good news
THE STREET·1h ago·3 min read
Business
Another summer camp files for Chapter 11 bankruptcy
THE STREET·25m ago·3 min read
Business
Amazon’s $700 2-in-1 laptop and tablet is 46% off during Prime Day
THE STREET·1h ago·3 min read
Related
On this beat
Business
Final stage of the bull market? What to do with your money now
THE STREET·49m ago·3 min read
Business
How a Viral Knicks Celebration Video Just Cost a High-Level JPMorgan Executive Her Job
INC·42m ago·3 min read
Business
Melania Trump and Donald Trump repeatedly butted heads over White House renovations, new book says
BI·46m ago·3 min read
Business
Bank of Canada Careful Not to Overreact to Inflation Pressure, Minutes Say
TWSJ·30m ago·3 min read